Intellectual Property Litigation - - BioPharm International

ADVERTISEMENT

Intellectual Property Litigation


BioPharm International
Volume 1, Issue 8

13. Bibby K, Davis J, Jones, J. Biopharmaceuticals—moving to centre stage. BioPeople. 2003:10 (available at http:// http://www.imshealth.com/vgn/images/portal/cit_40000873/43028586Bio_Moving_to_Centre_Stage.pdf ).

14. Benassi J, Wolff J. The rise of generic and "branded generics" cause dramatic increase in pharmaceutical patent litigation. IP Today. January 2004:8.

15. American Intellectual Property Law Association (AIPLA). Report of the Economic Survey. Arlington, Va: AIPLA; 2003:Table 22.

Gary N. Frischling, J.D., is a partner at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,

Keith A. Orso, J.D., is an associate at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here